中国临床药理学杂志Issue(5)：378-379,2.DOI:10.13699/j.cnki.1001-6821.2015.05.017
依达拉奉临床应用获益及其风险评价
Benefits and risks of edaravone in clinical application
王喆1
作者信息
- 1. 解放军总医院 第一附属医院 药剂药理科，北京 100048
- 折叠
摘要
Abstract
Since listed in May 2001, edaravone, as a novel free radical scavenger, was widely used in the treatment of acute cerebral infarction.With the expansion of the clinical application scope, its serious adverse reactions were gradually revealed.In order to provide a reference for rational use of edaravone combined with the patients ’ basic disease before treatment, this article reviewed literature about benefits and risks of edaravone in clinical application and then evaluated.关键词
依达拉奉/自由基清除剂/获益/风险Key words
edaravone/free radical scavenger/benefit/risk分类
医药卫生引用本文复制引用
王喆..依达拉奉临床应用获益及其风险评价[J].中国临床药理学杂志,2015,(5):378-379,2.
